한 대학병원의 혈액배양 결과 분석: 균종 분포와 누적 항생제 내성 양상(2016–2020)
Analysis of blood culture data at a university hospital: bacterial distribution and cumulative antimicrobial resistance (2016–2020)
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
배경: 혈류 감염에서 흔히 분리되는 균종 분포와 누적 항생제 감수성 양상은 초기 치료로써 경험적 항생제를 선택하는 근거가 된다. 따라서 개별 환자들의 혈액 배양 결과를 일관성 있게 수집하고 정확하게 분석하는 것이 중요하다. 방법: 2016년부터 2020년까지 한 대학병원 환자의 혈액 배양 결과를 후향적으로 분석하여 의미있는 병원균 분포 및 항생제 내성 양상을 파악하고자 하였다. 한 환자에서 같은 균종이 반복 분리되면 첫 번째 분리균만 포함하여 중복균을 제거하였다. 항생제 감수성 결과는 최소억제농도 값을이용하였으며 Clinical and Laboratory Standards Institute (CLSI) M100 ED30: 2020을 기준으로 해석하였다. 결과: 5년 동안 혈액 배양에서 가장 흔히 분리된 균은 Escherichia coli (27.1%)였고, Klebsiellapneumoniae (10.1%), Staphylococcus aureus (8.6%) 순이었다. S. aureus의 methicillin 내성률은 49.2%,E. faecium의 vancomycin 내성률은 39.5%였고 5년간 의미 있는 추세변화는 없었다. E. coli의cefotaxime, ciprofloxacin, ertapenem 내성률은 각각 35.0%, 46.8%, 0.7%였으며 총 17주의 carbapenem내성 E. coli가 분리되었고 이 중 11주가 carbapenemase 생성균이었다. K. pneumoniae의 cefotaxime,ciprofloxacin, ertapenem 내성률은 각각 29.5%, 31.7%, 5.4%였으며 총 48주의 carbapenem 내성 K. pneumoniae가 분리되었고 이 중 37주가 carbapenemase 생성균이었다. A. baumannii의 imipenem 내성률은 72.3%, P. aeruginosa의 imipenem 내성률은 23.4%로 5년간 추세변화는 없었다. 결론: 2016-2020년까지 혈액 배양에서 E. coli, K. pneumoniae, E. faecium 분리율은 증가추세였고S. aureus는 큰 변화가 없었다. 5년간 E. coli와 P. aeruginosa의 ciprofloxacin 내성률, A. baumannii의ampicillin/sulbactam 내성률이 증가추세를 나타냈다.
Abstract
Background: The distribution of bacteria isolated from bloodstream infections andcumulative antimicrobial susceptibility data are the basis for empirical decisions regardingantibiotics as an initial treatment. Therefore, it is important to consistently collect bloodculture results of individual patients and analyze them correctly. Methods: The blood culture results of patients at a university hospital from 2016 to 2020 wereanalyzed retrospectively to determine the bacterial distributions and antibiotic resistancepatterns. Duplicates were eliminated by including only the first isolate of each species perpatient. Results: Escherichia coli (27.1%) was the most commonly isolated bacterium from bloodcultures, followed by Klebsiella pneumoniae (10.1%) and Staphylococcus aureus (8.6%). Themethicillin resistance rate of S. aureus was 49.2%, and the vancomycin resistance rate ofEnterococcus faecium was 39.5%; with no significant changes over the study period. Thecefotaxime, ciprofloxacin, and ertapenem resistance rates of E. coli were 35.0%, 46.8%, and0.7%, respectively. Seventeen carbapenem-resistant E. coli strains were isolated, of which 11produced carbapenemase. The cefotaxime, ciprofloxacin, and ertapenem resistance rates ofK. pneumoniae were 29.5%, 31.7%, and 5.4%, respectively. Forty-eight carbapenem-resistantK. pneumoniae strains were isolated, of which 37 produced carbapenemase. The imipenemresistance rates of Acinetobacter baumannii and Pseudomonas aeruginosa were 72.3% and23.4%, respectively. Conclusion: In the blood culture results from 2016 to 2020, the isolation frequency of E. coli, K. pneumoniae, and E. faecium showed an increasing trend, whereas that of S. aureuswas stable. Over the 5 year study period, the ciprofloxacin resistance rate of E. coli and P. aeruginosa and ampicillin/sulbactam resistance rate of A. baumannii significantly increased.
참고문헌 (23)
- Ljungquist O, "Incidence, aetiology and temporal trend of bloodstream infections in southern Sweden from 2006 to 2019: a population-based study", Euro Surveill, 28, pp.2200519~ (2023)
- 신정환, "Comprehensive Analysis of Blood Culture Performed at Nine University Hospitals in Korea", Annals of Laboratory Medicine, 31(2), pp.101~106 (2011), 대한진단검사의학회
- 임상은, "Trends in Bloodstream Infections and Antimicrobial Susceptibilities at a University Hospital in Korea Between 2007 and 2016", Laboratory Medicine Online, 9(2), pp.63~72 (2019), 대한진단검사의학회[DOI]
- Kohlmann R, "Analysis and presentation of cumulative antimicrobial susceptibility test data–the influence of different parameters in a routine clinical microbiology laboratory", PloS One, 11, pp.e0147965~ (2016)
- Clinical and Laboratory Standard Institute, "Analysis and presentation of cumulative antimicrobial susceptibility test data. CLSI M39" (2022), CLSI
- 서일혜, "한 3차 대학병원의 혈액배양 분석(2006년-2015년)", Annals of Clinical Microbiology, 20(2), pp.35~41 (2017), 대한임상미생물학회
- Clinical and Laboratory Standard Institute, "Performance standards for antimicrobial susceptibility testing. CLSI M100" (2020), CLSI
- "WHONET 2022. The microbiology laboratory database software" (2022)[URL]
- Doern GV, "Practical guidance for clinical microbiology laboratories : a comprehensive update on the problem of blood culture contamination and a discussion of methods for addressing the problem", Clin Microbiol Rev, 33, pp.e00009-19~ (2019)
- Bekeris LG, "Trends in blood culture contamination : a College of American Pathologists Q-Tracks study of 356 institutions", Arch Pathol Lab Med, 129, pp.1222~1225 (2005)
- Alonso-Menchén D, "Unresolved issues in the epidemiology and diagnosis of bacteremia : an opinion paper", Rev Esp Quimioter, 35, pp.519~537 (2022)
- Wisplinghoff H, "Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study", Clin Infect Dis, 39, pp.309~317 (2004)
- Verway M, "Prevalence and mortality associated with bloodstream organisms : a population-wide retrospective cohort study", J Clin Microbiol, 60, pp.e0242921~ (2022)
- Diekema DJ, "The microbiology of bloodstream infection : 20-year trends from the SENTRY antimicrobial surveillance program", Antimicrob Agents Chemother, 63, pp.e00355-19~ (2019)
- Kim D, "Major bloodstream infectioncausing bacterial pathogens and their antimicrobial resistance in South Korea, 2017–2019:Phase I report from Kor-GLASS", Front Microbiol, 12, pp.799084~ (2022)
- Huh K, "Continuous increase of the antimicrobial resistance among gram-negative pathogens causing bacteremia : a nationwide surveillance study by the Korean Network for Study on Infectious Diseases(KONSID)", Diagn Microbiol Infect Dis, 76, pp.477~482 (2013)
- Elzi L, "How to discriminate contamination from bloodstream infection due to coagulase-negative staphylococci : a prospective study with 654 patients", Clin Microbiol Infect, 18, pp.E355~E361 (2012)
- 김낙현, "13년간 한 대학병원 혈액배양에서 분리된 균의 분포 및 항생제 감수성 변화 양상", Infection and Chemotherapy, 44(4), pp.275~281 (2012), 대한감염학회
- Inagaki K, "Methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia: nationwide estimates of 30-day readmission, in-hospital mortality, length of stay, and cost in the United States", Clin Infect Dis, 69, pp.2112~2118 (2019)
- 오태상, "Trends in Bloodstream Infections at a Korean University Hospital between 2008 and 2013", Annals of Clinical Microbiology, 18(1), pp.14~19 (2015), 대한임상미생물학회
- 김소영, "일개 대학병원의 5년간 혈액 배양에 대한 분석(2003∼2007)", Annals of Clinical Microbiology, 12(4), pp.163~168 (2009), 대한임상미생물학회
- Clinical and Laboratory Standard Institute, "Performance standards for antimicrobial susceptibility testing. CLSI M100" (2019), CLSI
- "Kor-GLASS"[URL]
